InsiderTrades.com logo
Natural is heading to the Nasdaq
From MedX   |   Ad
Natural solutions are already better for the environment. But there’s one company taking it a step further: Their natural pesticides outperform chemical alternatives. That’s already led to 200% revenue growth, thanks to e-commerce partnerships with companies like Walmart, Amazon, and Kroger.
See how you can become a shareholder while they’re still private.

AQST Insider Trading

Insider Ownership Percentage: 7.85%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $429,750.00

Aquestive Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aquestive Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aquestive Therapeutics Share Price & Price History

Current Price: $4.95
Price Change: ▲ Price Increase of +0.34 (7.38%)
As of 09/11/2024 01:00 AM ET

This chart shows the closing price history over time for AQST up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Trump’s weapon lurks in abandoned America
From Porter & Company   |   Ad
Whoever wins the presidential election – Trump or Harris – this energy surprise could see their popularity skyrocket… as a new period of wealth and prosperity sweeps across the nation… emanating from the last place anyone could have predicted. Now, billions of dollars are amassing behind this force, with everyone from Jeff Bezos and Bill Gates to Sam Altman and Warren Buffett pouring their money into this phenomenon.
To find out more about this American resurrection, go here now to watch my new documentary

Aquestive Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2024Alexander Mark SchobelInsiderSell50,000$6.00$300,000.00984,476View SEC Filing Icon  
3/8/2024Alexander Mark SchobelInsiderSell25,000$5.19$129,750.001,040,371View SEC Filing Icon  
6/14/2022Peter E BoydSVPBuy5,000$0.81$4,050.0059,532View SEC Filing Icon  
6/8/2022Alexander Mark SchobelInsiderBuy45,871$0.96$44,036.16882,871View SEC Filing Icon  
6/8/2022Daniel BarberCEOBuy91,743$0.96$88,073.28193,702View SEC Filing Icon  
6/8/2022Lori J BraenderGeneral CounselBuy13,761$0.96$13,210.5638,761View SEC Filing Icon  
6/8/2022Peter E BoydSVPBuy2,293$0.96$2,201.2854,532View SEC Filing Icon  
See Full Table
The #1 Altcoin for September 2024
From Crypto 101 Media   |   Ad
With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024.
Go here to get full details on this crypto now.

SEC Filings (Institutional Ownership Changes) for Aquestive Therapeutics (NASDAQ:AQST)

32.45% of Aquestive Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AQST by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aquestive Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/5/2024Sanctuary Advisors LLC63,270$0.17M0.0%N/A0.069%Search for SEC Filing on Google Icon
8/15/2024Blue Owl Capital Holdings LP1,140,000$2.96M0.8%+30.3%1.252%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company 29,371$76K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C146,155$0.38M0.0%N/A0.161%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP77,016$0.20M0.0%N/A0.085%Search for SEC Filing on Google Icon
8/12/2024Marathon Trading Investment Management LLC18,225$47K0.0%-79.8%0.020%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC496,200$1.29M0.0%-63.9%0.545%Search for SEC Filing on Google Icon
8/7/2024PFG Investments LLC59,000$0.15M0.0%+22.9%0.065%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.10,299$27K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers97,837$0.25M0.0%N/A0.107%Search for SEC Filing on Google Icon
7/29/2024Financial Advocates Investment Management34,000$88K0.0%+70.0%0.037%Search for SEC Filing on Google Icon
7/26/2024Legato Capital Management LLC242,371$0.63M0.1%-2.5%0.266%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp228,351$0.59M0.0%N/A0.251%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC102,836$0.44M0.0%+219.7%0.113%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC29,112$0.12M0.0%+115.5%0.032%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC533,567$2.27M0.0%-3.1%0.586%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.3,242,571$13.81M0.0%+71.7%3.562%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC12,625$54K0.0%N/A0.014%Search for SEC Filing on Google Icon
5/3/2024Essex Investment Management Co. LLC612,949$2.61M0.5%-27.6%0.673%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC341,860$1.46M0.0%N/A0.376%Search for SEC Filing on Google Icon
4/22/2024PFG Investments LLC48,000$0.20M0.0%N/A0.065%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC3,924,000$7.93M0.1%-18.3%5.877%Search for SEC Filing on Google Icon
2/8/2024Essex Investment Management Co. LLC846,167$1.71M0.3%N/A1.267%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC29,812$60K0.0%N/A0.045%Search for SEC Filing on Google Icon
1/25/2024Vahanian & Associates Financial Planning Inc.591,608$1.20M4.7%-18.1%0.886%Search for SEC Filing on Google Icon
1/16/2024Legato Capital Management LLC340,564$0.69M0.1%N/A0.510%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC4,800,000$7.34M0.1%+314.5%7.189%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.247,828$0.38M0.0%+14.2%0.371%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC550,484$0.84M0.0%+238.8%0.824%Search for SEC Filing on Google Icon
8/8/2023Kestra Private Wealth Services LLC16,732$28K0.0%N/A0.030%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC162,467$0.27M0.0%N/A0.291%Search for SEC Filing on Google Icon
8/4/2023HBK Sorce Advisory LLC42,348$70K0.0%-50.0%0.076%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can19,230$42K0.0%N/A0.034%Search for SEC Filing on Google Icon
5/11/2023Financial Advocates Investment Management25,000$28K0.0%-21.9%0.045%Search for SEC Filing on Google Icon
4/18/2023Vahanian & Associates Financial Planning Inc.718,908$0.82M2.3%+6.0%1.287%Search for SEC Filing on Google Icon
2/1/2023Vahanian & Associates Financial Planning Inc.678,258$0.61M2.0%-2.4%1.252%Search for SEC Filing on Google Icon
11/3/2022Vahanian & Associates Financial Planning Inc.695,258$0.81M2.8%+24.9%1.303%Search for SEC Filing on Google Icon
8/11/2022Beacon Pointe Advisors LLC60,000$38K0.0%N/A0.112%Search for SEC Filing on Google Icon
8/10/2022Mackenzie Financial Corp61,699$39K0.0%N/A0.116%Search for SEC Filing on Google Icon
8/5/2022Cowen AND Company LLC124,590$80K0.0%N/A0.281%Search for SEC Filing on Google Icon
7/27/2022Vahanian & Associates Financial Planning Inc.556,758$0.36M1.5%+7.0%1.257%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP34,769$91K0.0%-64.4%0.083%Search for SEC Filing on Google Icon
4/27/2022Vahanian & Associates Financial Planning Inc.520,158$1.36M3.1%-44.1%1.254%Search for SEC Filing on Google Icon
4/19/2022Graypoint LLC413,817$1.08M0.1%N/A0.998%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC91,611$0.36M0.0%+20.4%0.228%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP97,802$0.38M0.0%-67.1%0.244%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.28,382$0.11M0.0%N/A0.071%Search for SEC Filing on Google Icon
2/4/2022IndexIQ Advisors LLC81,213$0.32M0.0%-6.1%0.202%Search for SEC Filing on Google Icon
1/28/2022Vahanian & Associates Financial Planning Inc.929,975$3.62M2.9%N/A2.315%Search for SEC Filing on Google Icon
12/1/2021Balyasny Asset Management LLC148,061$0.65M0.0%N/A0.369%Search for SEC Filing on Google Icon
11/15/2021Balyasny Asset Management LLC148,061$0.65M0.0%N/A0.369%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP297,229$1.30M0.1%+203.9%0.740%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC189,669$0.83M0.0%-22.7%0.472%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC49,700$0.22M0.0%+62.3%0.124%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.73,165$0.32M0.0%+7.5%0.182%Search for SEC Filing on Google Icon
11/10/2021IndexIQ Advisors LLC86,461$0.38M0.0%+11.1%0.215%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC27,926$0.12M0.0%-11.0%0.070%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.330,946$1.44M0.0%-5.7%0.824%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC18,521$74K0.0%N/A0.048%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC437,854$1.74M0.0%N/A1.126%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC127,000$0.50M0.0%-16.4%0.327%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP217,091$0.86M0.0%N/A0.558%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC19,824$79K0.0%N/A0.051%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP12,090$48K0.0%N/A0.031%Search for SEC Filing on Google Icon
8/16/2021PDT Partners LLC81,765$0.33M0.0%N/A0.210%Search for SEC Filing on Google Icon
8/16/2021Alberta Investment Management Corp150,000$0.60M0.0%N/A0.386%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.74,757$0.30M0.0%-56.7%0.192%Search for SEC Filing on Google Icon
8/16/2021State Street Corp69,877$0.28M0.0%-78.4%0.180%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd78,100$0.31M0.1%N/A0.201%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.68,030$0.27M0.0%+45.3%0.175%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC245,448$0.97M0.0%N/A0.631%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp45,454$0.18M0.0%-78.6%0.117%Search for SEC Filing on Google Icon
8/13/2021Jump Financial LLC30,630$0.12M0.0%N/A0.079%Search for SEC Filing on Google Icon
8/13/2021Brandywine Global Investment Management LLC125,416$0.50M0.0%-7.9%0.323%Search for SEC Filing on Google Icon
8/13/2021Latash Investments LLC243,134$0.97M0.6%N/A0.625%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC219,642$0.87M0.0%-38.1%0.565%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,046,078$4.15M0.0%+22.1%2.690%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.125,411$0.50M0.0%+238.3%0.323%Search for SEC Filing on Google Icon
8/12/2021Bank of Montreal Can21,020$87K0.0%+365.6%0.054%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC90,900$0.36M0.0%N/A0.234%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp115,723$0.46M0.0%-29.5%0.298%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC15,644$62K0.0%N/A0.040%Search for SEC Filing on Google Icon
8/10/2021Cresset Asset Management LLC25,000$99K0.0%N/A0.064%Search for SEC Filing on Google Icon
8/6/2021HighTower Advisors LLC126,805$0.50M0.0%+84.8%0.347%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP97,801$0.39M0.0%-52.9%0.267%Search for SEC Filing on Google Icon
8/4/2021IndexIQ Advisors LLC77,801$0.31M0.0%-13.0%0.213%Search for SEC Filing on Google Icon
8/3/2021Financial Advocates Investment Management17,000$67K0.0%+30.8%0.046%Search for SEC Filing on Google Icon
6/17/2021Geneos Wealth Management Inc.23,300$94K0.0%N/A0.064%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley358,042$1.86M0.0%+929.7%0.978%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC13,360$69K0.0%-76.5%0.037%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC764,217$3.97M0.0%+43.9%2.088%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.46,826$0.24M0.0%-8.5%0.128%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd10,970$57K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP10,227$53K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC16,612$86K0.0%+159.0%0.045%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp164,259$0.85M0.0%+82.5%0.449%Search for SEC Filing on Google Icon
5/13/2021Massachusetts Financial Services Co. MA54,495$0.28M0.0%-10.6%0.149%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp212,402$1.10M0.0%-5.9%0.580%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC354,856$1.85M0.0%+13.3%0.970%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG14,174$74K0.0%-40.4%0.039%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aquestive Therapeutics logo
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. The company's proprietary pipeline of complex molecule product includes AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and Anaphylm, an epinephrine sublingual film for the emergency treatment of allergic reactions, including anaphylaxis. In addition, it develops Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.
Read More on Aquestive Therapeutics

Today's Range

Now: $4.95
Low: $4.57
High: $4.98

50 Day Range

MA: $3.65
Low: $2.40
High: $4.69

52 Week Range

Now: $4.95
Low: $1.25
High: $6.23

Volume

1,416,806 shs

Average Volume

1,834,884 shs

Market Capitalization

$450.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.84

Who are the company insiders with the largest holdings of Aquestive Therapeutics?

Aquestive Therapeutics' top insider shareholders include:
  1. Alexander Mark Schobel (Insider)
Learn More about top insider investors at Aquestive Therapeutics.

Who are the major institutional investors of Aquestive Therapeutics?

Aquestive Therapeutics' top institutional investors include:
  1. Blue Owl Capital Holdings LP — 1.25%
  2. Renaissance Technologies LLC — 0.55%
  3. Legato Capital Management LLC — 0.27%
  4. Bank of New York Mellon Corp — 0.25%
  5. Deerfield Management Company L.P. Series C — 0.16%
  6. Rhumbline Advisers — 0.11%
Learn More about top institutional investors of Aquestive Therapeutics stock.

Which major investors are selling Aquestive Therapeutics stock?

In the last quarter, AQST stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Marathon Trading Investment Management LLC
  3. Legato Capital Management LLC

Which major investors are buying Aquestive Therapeutics stock?

During the previous quarter, AQST stock was purchased by institutional investors including:
  1. Blue Owl Capital Holdings LP
  2. Bank of New York Mellon Corp
  3. Deerfield Management Company L.P. Series C
  4. Rhumbline Advisers
  5. Marshall Wace LLP
  6. Sanctuary Advisors LLC
  7. The Manufacturers Life Insurance Company
  8. Financial Advocates Investment Management
Natural is heading to the Nasdaq
From MedX   |   Ad
Natural solutions are already better for the environment. But there’s one company taking it a step further: Their natural pesticides outperform chemical alternatives. That’s already led to 200% revenue growth, thanks to e-commerce partnerships with companies like Walmart, Amazon, and Kroger.
See how you can become a shareholder while they’re still private.